Financials
Financial year 2025
Pharma Boulevard from Lier, company number BE0761844730, closed financial year 2025 with a result of € 181,302 after tax. For that financial year Pharma Boulevard recorded a gross margin of € 1 million and equity of € 491,905. Compared with financial year 2024, the result moved from € 187,805 to € 181,302. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 491,905
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 181,302
▼ 3% vs 2024
Profit after tax over the fiscal year.
€ 118,264
▲ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 75,000 paid out
41 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
12
▲ 1.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 636,640
▲ 19% vs 2024
€ 53,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 416,965
▼ 17% vs 2024
€ 68,608 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 989,759
▲ 31% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 77,669
▲ 29% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 441,785 | € 603,454 | € 912,569 | € 1,020,812 | ▲ 12% |
| Profit after taxes | € 29,199 | € 75,656 | € 187,805 | € 181,302 | ▼ 3% |
| Equity | € 122,142 | € 197,798 | € 385,603 | € 491,905 | ▲ 28% |
| Total debts | € 1,662,922 | € 1,591,402 | € 1,488,644 | € 1,771,054 | ▲ 19% |
| Cash | € 3,908 | € 82,897 | € 116,159 | € 118,264 | ▲ 2% |
| Land & buildings | € 591,554 | € 526,977 | € 462,620 | € 416,138 | ▼ 10% |
| Retained profit | € 17,763 | € 93,420 | € 281,225 | € 387,527 | ▲ 38% |
| Dividend | € 0 | € 0 | € 0 | € 75,000 | |
| Bank debt | € 958,627 | € 734,414 | € 504,557 | € 416,965 | ▼ 17% |
| Balance sheet total | € 1,785,063 | € 1,789,200 | € 1,874,247 | € 2,262,959 | ▲ 21% |
| Employees (FTE) | 6.6 | 8.2 | 10.8 | 12 | ▲ 1.2 |
By gross margin, Pharma Boulevard ranks 3rd of 6 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Lier that publish figures (fiscal year 2025).
Key figures of Pharma Boulevard, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Pharma Boulevard the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Pharma Boulevard?
What happened at Pharma Boulevard in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 181,302 (▼ 3% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Lier. KBO
In short
From € 29,199 profit in 2022 to € 181,302 profit in 2025.
Paid € 140,283 in corporate taxes since 2022.
Best year ever: 2024, with € 187,805 profit.
On average € 85,100 of value added per employee in 2025.
Management
Behind Pharma Boulevard are VIOS and JOKA. The same people are also behind Pharmentum, Animal Boulevard and Nature Avenue.
Directors
According to the 2025 annual accounts
Director · represented by Van den Acker Barbara
Also active at: Pharmentum, Animal Boulevard, Nature Avenue
Director · represented by Joeri Van den Acker
Also active at: Pharmentum, Animal Boulevard, Nature Avenue
Establishments
Establishment units
Physical locations of this company
Kelderveld 37 box 2
2500 Lier
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →Animal Boulevard same network
€ 405,621 gross margin · 2025
Nature Avenue same network
€ 2,793 gross margin · 2025
LASETO
€ 2.3 million gross margin · 2025
PETSOLUTIONS
€ 2.3 million gross margin · 2025
BUTTERSTONE DIAMOND TOOLS
€ 393,223 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Lier
Same main activity (Groothandel in farmaceutische en medische artikelen), 6 active companies in Lier, largest first.
€ 32.1 million revenue · 2025
€ 5.4 million gross margin · 2025
€ 3.9 million gross margin · 2022
€ 880,988 gross margin · 2025
€ 53,273 gross margin · 2025
€ 2,793 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VAN dEN ACKER Joeri Raymond Simonne(oprichter) 70%
- VAN dEN ACKER Barbara Nicole Freddy(oprichter) 30%
Details
- Company number
- 0761.844.730
- VAT number
- BE 0761.844.730
- Registered office
- Kelderveld 37 bus 2, 2500 Lier
- Names & denominations
- Pharma Boulevard
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 January 2021
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings